Hyperkalemia
Metabolic
Hyperkalemia is treated with 2 medications in our database, including Sodium Polystyrene Sulfonate, LOKELMA. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Concordia Pharmaceuticals, AstraZeneca. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Hyperkalemia treatment below.
What help exists for Hyperkalemia
5
drugs indexed
0
with copay cards
0
with patient assistance
1
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Hyperkalemia
5 totalVELTASSA
patiromer
LOKELMA
sodium zirconium cyclosilicate
Kionex
Sodium Polystyrene Sulfonate
SODIUM POLYSTYRENE SULFONATE
sodium polystyrene sulfonate · Sanofi
Amiloride Hydrochloride
amiloride hydrochloride · Merck
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Hyperkalemia drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |